Abstract
We investigated the early onset of molecular changes in the hippocampus of orchidectomy (ODX)-induced androgen-deficient rats. Transcript levels of the genes associated with loss of synaptic plasticity (Bdnf, Syn, GluN1, α7-nAChR, and M1-mAChR), formation of neurofibrillary tangles (Tau4 and Tau3), and amyloid plaques (App, Adam10, and Bace1), in the hippocampus of rats at 0, 1, 3, 6, and 9 days after ODX (D0, D1, D3, D6 and D9, respectively) were determined. Primarily, the sudden loss of androgen, as confirmed by the decreased serum testosterone levels and accessory sex organ weights, induced a chronological reduction in Syn (at D1), and increase in GluN1 (at D3), α7-nAChR, and M1-mAChR (at D6) and a decrease in Bdnf (at D9) transcript levels. Tau4 and Tau3 mRNA levels were increased at D6 and D9, respectively. No changes in App, Adam10, and Bace1 mRNA levels were detected within the 9-day study period. To confirm those changes were caused by androgen deprivation and not increasing age, the mRNA expression levels of those genes in 9-day orchidectomized rats (ODX-D9) were compared with age-matched intact rats. All changes of mRNA expression levels of the ODX-D9 rats were aligned with the D9 rats, except for GluN1 that was decreased in the ODX-D9 rats. Moreover, the total and phosphorylated tau protein levels were increased in the ODX-D9 rats. These results denote that androgen deficiency induces the early onset of neurodegeneration, while the loss of synaptic plasticity together with the formation of neurofibrillary tangles could be used as markers for neurodegenerative prediction.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Anukulthanakorn K, Malaivijitnond S, Kitahashi T, Jaroenporn S, Parhar I (2013) Molecular events during the induction of neurodegeneration and memory loss in estrogen-deficient rats. Gen Comp Endocrinol 181:316–323. https://doi.org/10.1016/j.ygcen.2012.07.034
Auld DS, Kornecook TJ, Bastianetto S, Quirion R (2002) Alzheimer’s disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol 68:209–245
Axell AM, MacLean HE, Plant DR, Harcourt LJ, Davis JA, Jimenez M, Handelsman DJ, Lynch GS, Zajac JD (2006) Continuous testosterone administration prevents skeletal muscle atrophy and enhances resistance to fatigue in orchidectomized male mice. Am J Phys Endocrinol Metab 291:E506–E516. https://doi.org/10.1152/ajpendo.00058.2006
Barron AM, Pike CJ (2012) Sex hormones, aging, and Alzheimer’s disease. Front Biosci 4:976–997
Bennett MR, Lagopoulos J (2014) Stress and trauma: BDNF control of dendritic-spine formation and regression. Prog Neurobiol 112:80–99. https://doi.org/10.1016/j.pneurobio.2013.10.005
Bertoni-Freddari C, Fattoretti P, Solazzi M, Giorgetti B, Di Stefano G, Casoli T, Meier-Ruge W (2003) Neuronal death versus synaptic pathology in Alzheimer’s disease. Ann N Y Acad Sci 1010:635–638
Borst SE, Conover CF (2006) Orchiectomized Fischer 344 male rat models body composition in hypogonadal state. Life Sci 79:411–415. https://doi.org/10.1016/j.lfs.2006.01.035
Burger HG, Dudley EC, Robertson DM, Dennerstein L (2002) Hormonal changes in the menopause transition. Recent Prog Horm Res 57:257–275
Butler L, Santoro N (2011) The reproductive endocrinology of the menopausal transition. Steroids 76:627–635. https://doi.org/10.1016/j.steroids.2011.02.026
Chai JK, Blaha V, Meguid MM, Laviano A, Yang ZJ, Varma M (1999) Use of orchiectomy and testosterone replacement to explore meal number-to-meal size relationship in male rats. Am J Phys 276:R1366–R1373
Cohen-Cory S, Kidane AH, Shirkey NJ, Marshak S (2010) Brain-derived neurotrophic factor and the development of structural neuronal connectivity. Dev Neurobiol 70:271–288. https://doi.org/10.1002/dneu.20774
Counts SE, He B, Che S, Ikonomovic MD, DeKosky ST, Ginsberg SD, Mufson EJ (2007) α7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease. Arch Neurol 64:1771–1776. https://doi.org/10.1001/archneur.64.12.1771
Creese I, Sibley DR (1981) Receptor adaptations to centrally acting drugs. Annu Rev Pharmacol Toxicol 21:357–391. https://doi.org/10.1146/annurev.pa.21.040181.002041
Drummond ES, Harvey AR, Martins RN (2009) Androgens and Alzheimer’s disease. Curr Opin Endocrinol Diabetes Obes 16:254–259. https://doi.org/10.1097/MED.0b013e32832b101f
English HF, Santen RJ, Isaacs JT (1987) Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 11:229–242
Fuller SJ, Tan RS, Martins RN (2007) Androgens in the etiology of Alzheimer’s disease in aging men and possible therapeutic interventions. J Alzheimers Dis 12:129–142
Gao W, Reiser PJ, Coss CC, Phelps MA, Kearbey JD, Miller DD, Dalton JT (2005) Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats. Endocrinology 146:4887–4897. https://doi.org/10.1210/en.2005-0572
Gentry RT, Wade GN (1976) Androgenic control of food intake and body weight in male rats. J Comp Physiol Psychol 90:18–25
Ghosal K, Fan Q, Dawson HN, Pimplikar SW (2016) Tau protein mediates APP intracellular domain (AICD)-induced Alzheimer’s-like pathological features in mice. PLoS One 11:e0159435. https://doi.org/10.1371/journal.pone.0159435
Gómez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, Parisi JE, Hyman BT (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer’s disease. Ann Neurol 41:17–24. https://doi.org/10.1002/ana.410410106
Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR (2001) Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 86:724–731. https://doi.org/10.1210/jcem.86.2.7219
Hatanaka Y, Hojo Y, Mukai H, Murakami G, Komatsuzaki Y, Kim J, Ikeda M, Hiragushi A, Kimoto T, Kawato S (2015) Rapid increase of spines by dihydrotestosterone and testosterone in hippocampal neurons: dependence on synaptic androgen receptor and kinase networks. Brain Res 1621:121–132. https://doi.org/10.1016/j.brainres.2014.12.011
Hellström-Lindahl E, Mousavi M, Zhang X, Ravid R, Nordberg A (1999) Regional distribution of nicotinic receptor subunit mRNAs in human brain: comparison between Alzheimer and normal brain. Mol Brain Res 66:94–103
Horch HW, Katz LC (2002) BDNF release from single cells elicits local dendritic growth in nearby neurons. Nat Neurosci 5:1177–1184. https://doi.org/10.1038/nn927
Huo DS, Sun JF, Zhang B, Yan XS, Wang H, Jia JX, Yang ZJ (2016) Protective effects of testosterone on cognitive dysfunction in Alzheimer’s disease model rats induced by oligomeric beta amyloid peptide 1-42. J Toxic Environ Health A 79:856–863. https://doi.org/10.1080/15287394.2016.1193114
Ikonomovic MD, Mufson EJ, Wuu J, Cochran EJ, Bennett DA, DeKosky ST (2003) Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer’s neuropathology. J Alzheimers Dis 5:39–48
Inoue T, Zakikhani M, David S, Algire C, Blouin MJ, Pollak M (2010) Effects of castration on insulin levels and glucose tolerance in the mouse differ from those in man. Prostate 70:1628–1635. https://doi.org/10.1002/pros.21198
Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, Wölfing H, Chieng BC, Christie MDJ, Napier IA, Eckert A, Staufenbiel M, Hardeman E, Götz J (2010) Dendritic function of tau mediates amyloid-β toxicity in Alzheimer’s disease mouse models. Cell 142:387–397. https://doi.org/10.1016/j.cell.2010.06.036
Jaffe AB, Hall A (2005) Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 21:247–269. https://doi.org/10.1146/annurev.cellbio.21.020604.150721
Kang L, Li S, Xing Z, Li J, Su Y, Fan P, Wang L, Cui H (2014) Dihydrotestosterone treatment delays the conversion from mild cognitive impairment to Alzheimer’s disease in SAMP8 mice. Horm Behav 65:505–515. https://doi.org/10.1016/j.yhbeh.2014.03.017
Kashiwagi B, Shibata Y, Ono Y, Suzuki R, Honma S, Suzuki K (2005) Changes in testosterone and dihydrotestosterone levels in male rat accessory sex organs, serum, and seminal fluid after castration: establishment of a new highly sensitive simultaneous androgen measurement method. J Androl 26:586–591. https://doi.org/10.2164/jandrol.04164
Kerr JE, Allore RJ, Beck SG, Handa RJ (1995) Distribution and hormonal regulation of androgen receptor (AR) and AR messenger ribonucleic acid in the rat hippocampus. Endocrinology 136:3213–3221. https://doi.org/10.1210/endo.136.8.7628354
Ksiezak-Reding H, Liu WK, Yen SH (1992) Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments. Brain Res 597:209–219
Lau CF, Ho YS, Hung CHL, Wuwongse S, Poon CH, Chiu K, Yang X, Chu LW, Chang RCC (2014) Protective effects of testosterone on presynaptic terminals against oligomeric β-amyloid peptide in primary culture of hippocampal neurons. Biomed Res Int 2014:103906. https://doi.org/10.1155/2014/103906
Leifke E, Gorenoi V, Wichers C, Von Zur Mühlen A, Von Büren E, Brabant G (2000) Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men: cross-sectional data from a healthy male cohort. Clin Endocrinol 53:689–695
Leranth C, Petnehazy O, MacLusky NJ (2003) Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats. J Neurosci 23:1588–1592
Li R, Singh M (2014) Sex differences in cognitive impairment and Alzheimer’s disease. Front Neuroendocrinol 35:385–403. https://doi.org/10.1016/j.yfrne.2014.01.002
Li S, Kang L, Zhang C, Xie G, Li N, Zhang Y, du J, Cui H (2013) Effects of dihydrotestosterone on synaptic plasticity of hippocampus in male SAMP8 mice. Exp Gerontol 48:778–785. https://doi.org/10.1016/j.exger.2013.04.014
Liao GY, Bouyer K, Kamitakahara A, Sahibzada N, Wang CH, Rutlin M, Simerly RB, Xu B (2015) Brain-derived neurotrophic factor is required for axonal growth of selective groups of neurons in the arcuate nucleus. Mol Metab 4:471–482. https://doi.org/10.1016/j.molmet.2015.03.003
Moffat SD, Zonderman AB, Metter EJ, Kawas C, Blackman MR, Harman SM, Resnick SM (2004) Free testosterone and risk for Alzheimer disease in older men. Neurology 62:188–193
Mufson EJ, Ginsberg SD, Ikonomovic MD, DeKosky ST (2003) Human cholinergic basal forebrain: chemoanatomy and neurologic dysfunction. J Chem Neuroanat 26:233–242
Nakamura N, Fujita H, Kawata M (2002) Effects of gonadectomy on immunoreactivity for choline acetyltransferase in the cortex, hippocampus, and basal forebrain of adult male rats. Neuroscience 109:473–485
OECD (2009) Test No. 441: Hershberger bioassay in rats: a short-term screening assay for (anti)androgenic properties. Organisation for Economic Co-operation and Development, Paris. https://doi.org/10.1787/9789264076334-en
Ottem EN, Beck LA, Jordan CL, Breedlove SM (2007) Androgen-dependent regulation of brain-derived neurotrophic factor and tyrosine kinase B in the sexually dimorphic spinal nucleus of the bulbocavernosus. Endocrinology 148:3655–3665. https://doi.org/10.1210/en.2007-0308
Papasozomenos SC (1997) The heat shock-induced hyperphosphorylation of tau is estrogen-independent and prevented by androgens: implications for Alzheimer disease. Proc Natl Acad Sci U S A 94:6612–6617
Papasozomenos S, Shanavas A (2002) Testosterone prevents the heat shock-induced overactivation of glycogen synthase kinase-3β but not of cyclin-dependent kinase 5 and c-Jun NH2-terminal kinase and concomitantly abolishes hyperphosphorylation of tau: implications for Alzheimer’s disease. Proc Natl Acad Sci U S A 99:1140–1145. https://doi.org/10.1073/pnas.032646799
Penzes P, Beeser A, Chernoff J, Schiller MR, Eipper BA, Mains RE, Huganir RL (2003) Rapid induction of dendritic spine morphogenesis by trans-synaptic EphrinB-EphB receptor activation of the Rho-GEF kalirin. Neuron 37:263–274
Pike CJ, Carroll JC, Rosario ER, Barron AM (2009) Protective actions of sex steroid hormones in Alzheimer’s disease. Front Neuroendocrinol 30:239–258. https://doi.org/10.1016/j.yfrne.2009.04.015
Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, Ferri CP (2013) The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement 9:63–75. https://doi.org/10.1016/j.jalz.2012.11.007
Quintela T, Marcelino H, Goncalves I, Patriarca FM, Santos CRA (2015) Gene expression profiling in the hippocampus of orchidectomized rats. J Mol Neurosci 55:198–205. https://doi.org/10.1007/s12031-014-0304-9
Ramsden M, Nyborg AC, Murphy MP, Chang L, Stanczyk FZ, Golde TE, Pike CJ (2003) Androgens modulate β-amyloid levels in male rat brain. J Neurochem 87:1052–1055
Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L (2007) Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer’s disease mouse model. Science 316:750–754. https://doi.org/10.1126/science.1141736
Romeo RD, Staub D, Jasnow AM, Karatsoreos IN, Thornton JE, McEwen BS (2005) Dihydrotestosterone increases hippocampal N-methyl-D-aspartate binding but does not affect choline acetyltransferase cell number in the forebrain or choline transporter levels in the CA1 region of adult male rats. Endocrinology 146:2091–2097. https://doi.org/10.1210/en.2004-0886
Rosario ER, Carroll JC, Oddo S, LaFerla FM, Pike CJ (2006) Androgens regulate the development of neuropathology in a triple transgenic mouse model of Alzheimer’s disease. J Neurosci 26:13384–13389. https://doi.org/10.1523/JNEUROSCI.2514-06.2006
Rosario ER, Carroll J, Pike CJ (2010) Testosterone regulation of Alzheimer-like neuropathology in male 3xTg-AD mice involves both estrogen and androgen pathways. Brain Res 1359:281–290. https://doi.org/10.1016/j.brainres.2010.08.068
Rosario ER, Carroll JC, Pike CJ (2012) Evaluation of the effects of testosterone and luteinizing hormone on regulation of β-amyloid in male 3xTg-AD mice. Brain Res 1466:137–145. https://doi.org/10.1016/j.brainres.2012.05.011
Sarkey S, Azcoitia I, Garcia-Segura LM, Garcia-Ovejero D, DonCarlos LL (2008) Classical androgen receptors in non-classical sites in the brain. Horm Behav 53:753–764. https://doi.org/10.1016/j.yhbeh.2008.02.015
Scheff SW, Price DA (2003) Synaptic pathology in Alzheimer’s disease: a review of ultrastructural studies. Neurobiol Aging 24:1029–1046
Scheff SW, Price DA, Schmitt FA, Mufson EJ (2006) Hippocampal synaptic loss in early Alzheimer’s disease and mild cognitive impairment. Neurobiol Aging 27:1372–1384. https://doi.org/10.1016/j.neurobiolaging.2005.09.012
Shankar GM, Bloodgood BL, Townsend M, Walsh DM, Selkoe DJ, Sabatini BL (2007) Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci 27:2866–2875. https://doi.org/10.1523/JNEUROSCI.4970-06.2007
Simerly RB, Chang C, Muramatsu M, Swanson LW (1990) Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J Comp Neurol 294:76–95. https://doi.org/10.1002/cne.902940107
Smith MD, Jones LS, Wilson MA (2002) Sex differences in hippocampal slice excitability: role of testosterone. Neuroscience 109:517–530
Takemoto-Kimura S, Ageta-Ishihara N, Nonaka M, Adachi-Morishima A, Mano T, Okamura M, Fujii H, Fuse T, Hoshino M, Suzuki S, Kojima M, Mishina M, Okuno H, Bito H (2007) Regulation of dendritogenesis via a lipid-raft-associated Ca2+/calmodulin-dependent protein kinase CLICK-III/CaMKIγ. Neuron 54:755–770. https://doi.org/10.1016/j.neuron.2007.05.021
Teaktong T, Graham AJ, Court JA, Perry RH, Jaros E, Johnson M, Hall R, Perry EK (2004) Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer’s disease and dementia with Lewy bodies: differential neuronal and astroglial pathology. J Neurol Sci 225:39–49. https://doi.org/10.1016/j.jns.2004.06.015
Tolwani RJ, Buckmaster PS, Varma S, Cosgaya JM, Wu Y, Suri C, Shooter EM (2002) BDNF overexpression increases dendrite complexity in hippocampal dentate gyrus. Neuroscience 114:795–805
Valtorta F, Pennuto M, Bonanomi D, Benfenati F (2004) Synaptophysin: leading actor or walk-on role in synaptic vesicle exocytosis? Bioessays 26:445–453. https://doi.org/10.1002/bies.20012
Verhovshek T, Cai Y, Osborne MC, Sengelaub DR (2010) Androgen regulates brain-derived neurotrophic factor in spinal motoneurons and their target musculature. Endocrinology 151:253–261. https://doi.org/10.1210/en.2009-1036
Wallace TL, Porter RH (2011) Targeting the nicotinic alpha7 acetylcholine receptor to enhance cognition in disease. Biochem Pharmacol 82:891–903. https://doi.org/10.1016/j.bcp.2011.06.034
Yamasaki K, Sawaki M, Muroi T, Takatsuki M (2001) Changes in the weights of the accessory sex organs in male CD/IGS rats (Rattus norvegicus) after castration. Contemp Top Lab Anim Sci 40:25–26
Acknowledgements
This work was supported by The Grant for International Research Integration: Chula Research Scholar, Ratchadaphiseksomphot Endowment Fund (to S. Malaivijitnond). The authors also would like to thank Dr. Robert Butcher, Chulalongkorn University, for proofreading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Fainanta, T., Jaroenporn, S., Wititsuwankul, P. et al. Chronological Molecular Changes in Neuronal Communication in Androgen-Deficient Rats. J Mol Neurosci 69, 83–93 (2019). https://doi.org/10.1007/s12031-019-01335-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12031-019-01335-7